IP Library Granted Patent US 7,855,291
Granted Patent B2
US 7,855,291 · App. 11/647,517 · Granted Dec 21, 2010

Process for the preparation of substituted phenylalanines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,855,291
App. No.
11/647,517
Granted
Dec 21, 2010
Kind
B2
Abstract

Intermediates and synthetic processes for the preparation of substituted phenylalanine-based compounds (e.g., of Formula I) are disclosed:

Claims (44)

1. A method of preparing a compound of formula I(a):

which comprises contacting a compound of formula II:

with a compound of formula III:

under conditions sufficient for the formation of the compound of formula I(a), wherein:

A is optionally substituted cycloalkyl, aryl, or heterocycle;

X is O, S, or NR 6 ;

Y 1 is halogen;

P 1 is R 1 or a protecting group;

P 2 is a protecting group;

P 3 is OR 2 , SR 2 , NR 9 R 10 , or NHNHR 9 ;

R 1 is hydrogen or optionally substituted alkyl, alkyl-aryl, alkyl-heterocycle, aryl, or heterocycle;

R 2 is hydrogen or optionally substituted alkyl, alkyl-aryl, alkyl-heterocycle, aryl, or heterocycle;

R 3 is hydrogen, cyano, or optionally substituted alkyl or aryl;

R 4 is hydrogen, cyano, or optionally substituted alkyl or aryl;

R 6 is hydrogen or optionally substituted alkyl or aryl;

R 7 is independently hydrogen, cyano, nitro, halogen, OR 8 , NR 9 R 10 , or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

each R 8 is independently hydrogen or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

each R 9 is independently hydrogen, a protecting group, or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

each R 10 is independently hydrogen, a protecting group, or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle; and

n is 1-4.

2. The method of claim 1 , wherein the compound of formula II is of formula II(a):

wherein:

each R 11 is independently hydrogen, cyano, nitro, halogen, OR 8 , NR 9 R 10 , or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

each R 12 is independently hydrogen, cyano, nitro, halogen, OR 8 , NR 9 R 10 , or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

m is 1-5; and

p is 1-4.

3. The method of claim 2 , wherein the compound of formula II(a) is of formula II(b):

4. The method of claim 1 , which further comprises deprotecting the compound of formula I(a) to provide a compound of formula I:

5. The method of claim 4 , wherein the compound of formula I is of formula I(b):

wherein:

each R 11 is independently hydrogen, cyano, nitro, halogen, OR 8 , NR 9 R 10 , or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

each R 12 is independently hydrogen, cyano, nitro, halogen, OR 8 , NR 9 R 10 , or optionally substituted alkyl, alkyl-aryl or alkyl-heterocycle;

m is 1-5; and

p is 1-4.

6. The method of claim 5 , wherein the compound of formula I(b) is of formula I(c):

7. The method of claim 6 , wherein the compound of formula I(c) is of formula I(d):

8. The method of claim 6 , wherein the compound of formula I(d) is of formula I(e):

9. A compound of the formula:

or a salt or solvate thereof, wherein:

P 1 is R 1 , aryl-alkyl, heteroaryl-alkyl, or —C(O)R 13 ;

P 2 is aryl-alkyl, heteroaryl-alkyl, or —C(O)R 13 ;

R 1 is hydrogen or optionally substituted alkyl, alkyl-aryl, alkyl-heterocycle, aryl, or heterocycle; and

each R 13 is independently alkyl, aryl-alkyl, aryl, heterocycle, alkoxy, aryloxy, or aryl-alkoxy.

10. The compound of claim 9 , which is of the formula:

Assignments (12)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENTS AT R/F 41939/0487, 46591/0544 AND 53940/0001 Recorded Apr 15, 2026
From: MIDCAP FINANCIAL TRUST
To: TERSERA THERAPEUTICS LLC,
Reel/Frame 075420/0453 →
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT RECORDED AT R/F 63227/0852 Recorded Jan 7, 2025
From: NEWSTONE CAPITAL PARTNERS, LLC
To: TERSERA THERAPEUTICS LLC
Reel/Frame 069835/0704 →
SECURITY INTEREST Recorded Apr 5, 2023
From: TERSERA THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 063227/0852 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2023
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: TERSERA THERAPEUTICS LLC
Reel/Frame 063253/0942 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2023
From: NEWSTONE CAPITAL PARTNERS, LLC
To: TERSERA THERAPEUTICS LLC; JDP THERAPEUTICS LLC
Reel/Frame 063221/0546 →
SECURITY INTEREST Recorded Apr 4, 2023
From: TERSERA THERAPEUTICS LLC
To: ANTARES CAPITAL LP, AS AGENT
Reel/Frame 063215/0724 →
SECURITY INTEREST Recorded Sep 30, 2020
From: TERSERA THERAPEUTICS LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 053940/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: LEXICON PHARMACEUTICALS, INC.
To: TERSERA THERAPEUTICS LLC
Reel/Frame 053763/0754 →
SECURITY INTEREST Recorded Sep 9, 2020
From: TERSERA THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 053721/0037 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2007
From: KANAMARLAPUDI, RAMANAIAH C.; PICKERSGILL, IAIN FRASER; SHI, ZHI-CAI; WU, WENXUE; ZHANG, HAIMING; BURGOON, HUGH ALFRED, JR.
To: LEXICON GENETICS INCORPORATED
Reel/Frame 019100/0097 →